• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
HLA Antigens Shed from the Surface of Synthetic or Naturally Occurred Platelet-Derived Microparticles During Storage of Platelet Concentrate.血小板浓缩液储存期间,合成或天然存在的血小板衍生微粒表面脱落的HLA抗原。
Indian J Hematol Blood Transfus. 2012 Sep;28(3):152-6. doi: 10.1007/s12288-011-0120-0. Epub 2011 Oct 20.
2
Glycoproteins of GpIbα and GpIIbIIIa on the Synthetic or Naturally Occurred Platelet-Derived Microparticles.
Indian J Hematol Blood Transfus. 2013 Sep;29(3):134-8. doi: 10.1007/s12288-012-0170-y. Epub 2012 Jul 4.
3
Production and characterization of liquid-stored and lyophilized reconstituted human infusible platelet membranes.液体储存和冻干重构人不可输注血小板膜的生产和特性。
Int J Lab Hematol. 2011 Dec;33(6):586-92. doi: 10.1111/j.1751-553X.2011.01354.x. Epub 2011 Jun 27.
4
Infusible platelet membrane microvesicles: a potential transfusion substitute for platelets.
Transfusion. 1996 Jun;36(6):536-42. doi: 10.1046/j.1537-2995.1996.36696269513.x.
5
HLA molecule expression on the surface of cells and microparticles in platelet concentrates.血小板浓缩物中细胞和微颗粒表面的 HLA 分子表达。
Transfusion. 2021 Apr;61(4):1023-1028. doi: 10.1111/trf.16201. Epub 2020 Nov 25.
6
Platelet storage media change the expression characteristics of the platelet-derived microparticles.血小板储存介质改变血小板衍生微粒的表达特征。
Indian J Hematol Blood Transfus. 2014 Sep;30(3):169-74. doi: 10.1007/s12288-012-0227-y. Epub 2013 Jan 24.
7
Platelets do not adsorb HLA class I molecules during storage of pooled platelet concentrates.在混合血小板浓缩物储存期间,血小板不会吸附I类人白细胞抗原分子。
Transfus Med. 2006 Jun;16(3):176-83. doi: 10.1111/j.1365-3148.2006.00664.x.
8
Effects of the addition of second-messenger effectors to platelet concentrates separated from whole-blood donations and stored at 4 degrees C or -80 degrees C.向从全血捐献中分离并储存于4℃或-80℃的血小板浓缩物中添加第二信使效应物的效果。
Transfusion. 2000 May;40(5):527-34. doi: 10.1046/j.1537-2995.2000.40050527.x.
9
Infusible platelet membranes improve hemostasis in thrombocytopenic blood: experimental studies under flow conditions.可输注血小板膜改善血小板减少血液中的止血功能:流动条件下的实验研究
Transfusion. 2000 Sep;40(9):1074-80. doi: 10.1046/j.1537-2995.2000.40091074.x.
10
Determination viability of a transfused platelet product by corrected count increment and percentage platelet response.通过校正计数增加值和血小板反应百分比来确定输注血小板产品的活力。
Pan Afr Med J. 2017 Jul 28;27:226. doi: 10.11604/pamj.2017.27.226.12116. eCollection 2017.

引用本文的文献

1
Interaction of Platelet-Derived Microparticles with a Human B-Lymphoblast Cell Line: A Clue for the Immunologic Function of the Microparticles.血小板衍生微粒与人B淋巴母细胞系的相互作用:微粒免疫功能的线索
Transfus Med Hemother. 2018 Jan;45(1):55-61. doi: 10.1159/000479072. Epub 2017 Sep 26.
2
Glycoproteins of GpIbα and GpIIbIIIa on the Synthetic or Naturally Occurred Platelet-Derived Microparticles.
Indian J Hematol Blood Transfus. 2013 Sep;29(3):134-8. doi: 10.1007/s12288-012-0170-y. Epub 2012 Jul 4.

本文引用的文献

1
Production and characterization of liquid-stored and lyophilized reconstituted human infusible platelet membranes.液体储存和冻干重构人不可输注血小板膜的生产和特性。
Int J Lab Hematol. 2011 Dec;33(6):586-92. doi: 10.1111/j.1751-553X.2011.01354.x. Epub 2011 Jun 27.
2
Current concepts in platelet transfusion.血小板输注的当前概念。
Asian J Transfus Sci. 2009 Jan;3(1):18-21. doi: 10.4103/0973-6247.45257.
3
Role of platelet-derived microparticles in angiogenesis and tumor progression.血小板衍生微粒在血管生成和肿瘤进展中的作用。
Discov Med. 2009 Dec;8(43):237-41.
4
A mini-review on platelet refractoriness.血小板输注无效的小型综述。
Haematologica. 2005 Feb;90(2):247-53.
5
Cellular microparticles: new players in the field of vascular disease?细胞微粒:血管疾病领域的新角色?
Eur J Clin Invest. 2004 Jun;34(6):392-401. doi: 10.1111/j.1365-2362.2004.01355.x.
6
Substitutes and alternatives to platelet transfusions in thrombocytopenic patients.
J Thromb Haemost. 2003 Jul;1(7):1637-41. doi: 10.1046/j.1538-7836.2003.00332.x.
7
Novel treatment modalities: new platelet preparations and substitutes.新型治疗方式:新型血小板制剂及替代品。
Br J Haematol. 2001 Sep;114(3):496-505. doi: 10.1046/j.1365-2141.2001.03004.x.
8
Novel platelet products, substitutes and alternatives.新型血小板制品、替代品及替代物。
Transfus Clin Biol. 2001 Jun;8(3):267-71. doi: 10.1016/s1246-7820(01)00127-6.
9
Infusible platelet membranes retain partial functionality of the platelet GPIb/IX/V receptor complex.
Am J Clin Pathol. 2001 Jan;115(1):144-7. doi: 10.1309/CCDV-3BEP-XXKP-BKDM.
10
Platelet substitutes and novel platelet products.血小板替代物和新型血小板制品。
Expert Opin Investig Drugs. 2000 Mar;9(3):457-69. doi: 10.1517/13543784.9.3.457.

血小板浓缩液储存期间,合成或天然存在的血小板衍生微粒表面脱落的HLA抗原。

HLA Antigens Shed from the Surface of Synthetic or Naturally Occurred Platelet-Derived Microparticles During Storage of Platelet Concentrate.

作者信息

Yari Fatemeh, Ahmadzadeh Noushin, Azadpour Shima, Vaeli Shahram

机构信息

Research Center, Iranian Blood Transfusion Organization, 14665-1157 Tehran, Iran.

出版信息

Indian J Hematol Blood Transfus. 2012 Sep;28(3):152-6. doi: 10.1007/s12288-011-0120-0. Epub 2011 Oct 20.

DOI:10.1007/s12288-011-0120-0
PMID:23997451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3422389/
Abstract

The demand for standard platelet concentrates (PCs) has continued to increase in the recent years. Infusible platelet membranes (IPM) prepared from new or outdated human platelets have been developed as an alternative to standard PCs, with the additional advantage of long shelf life and increased viral safety. Reduction of HLA antigens on the IPM has been assigned as one of the probable advantages of this product. In re-examining this issue, we studied the existence of HLA class I on the surface of IPM microparticles. In comparison we also surveyed HLA expression on the surface of the naturally occurred platelet-derived microparticles (nPMPs) during 7 days storage. Intended for producing IPM, PCs obtained from Iranian blood transfusion organization were lysed; virally inactivated with wet heat in the presence of a heat stabilizer and then sonicated. IPMs were separated using centrifugation and liquid-stored in 4°C. The expression of HLA class I antigens was surveyed using flow cytometry technique. HLA molecules were present on the microparticles. Shedding of HLA antigens was demonstrated from the surface of the both liquid-stored IPM and nPMPs during storage. Storage of IPM in 4°C was accompanied with significant reduction of HLA molecules. It seemed that achievement of HLA-free IPM could be impossible unless chloroquine treated platelets were used to prepare these microvesicles.

摘要

近年来,对标准血小板浓缩物(PCs)的需求持续增长。由新鲜或过期人血小板制备的可输注血小板膜(IPM)已被开发出来作为标准PCs的替代品,具有保质期长和病毒安全性提高的额外优势。降低IPM上的HLA抗原被认为是该产品的可能优势之一。在重新审视这个问题时,我们研究了IPM微粒表面是否存在HLA I类分子。作为对比,我们还调查了天然存在的血小板衍生微粒(nPMPs)在储存7天期间表面的HLA表达情况。为了制备IPM,将从伊朗输血组织获得的PCs进行裂解;在热稳定剂存在下用湿热进行病毒灭活,然后进行超声处理。通过离心分离IPM,并在4°C下液体储存。使用流式细胞术技术检测HLA I类抗原的表达。微粒上存在HLA分子。在储存期间,液体储存的IPM和nPMPs表面均出现HLA抗原脱落。将IPM储存在4°C会伴随着HLA分子的显著减少。除非使用经氯喹处理的血小板来制备这些微泡,否则似乎不可能获得无HLA的IPM。